Home > Income Statement > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Revenue

    Back to Income Statement
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹113 Cr₹109 Cr₹40 Cr₹31 Cr₹61 Cr

What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?

The latest Revenue ratio of OXYGENTA PHARMACEUTICAL is ₹113 Cr based on Mar2026 Standalone results.
Year Revenue
Mar2026₹113 Cr
Mar2025₹109 Cr
Mar2024₹40 Cr
Mar2023₹31 Cr
Mar2022₹61 Cr

How is Revenue of OXYGENTA PHARMACEUTICAL Trending?

Years Revenue % Change
Mar2026 ₹113 Cr
3.37
Mar2025 ₹109 Cr
175.72
Mar2024 ₹40 Cr
27.93
Mar2023 ₹31 Cr
-48.80
Mar2022 ₹61 Cr -

Compare Revenue of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹203.5 Cr -7.5% 12.2% -27% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,791.0 Cr 1.7% -1.4% 21.7% Stock Analytics
DIVIS LABORATORIES ₹245,081.0 Cr 2% 10.3% 49.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,351.0 Cr -0.4% -0.5% 38.6% Stock Analytics
CIPLA ₹114,163.0 Cr -0.5% -2.5% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,906.3 Cr -1.2% 0% -7.1% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-7.5%

12.2%

-27%

SENSEX

-1.2%

-2.6%

-5.2%


You may also like the below Video Courses